H.R. 4818

House

Treat and Reduce Obesity Act of 2023

In debate

The bill is being debated or has cleared committee and is moving toward a floor vote.

In brief

This bill expands Medicare coverage to include FDA-approved medications for chronic weight management in individuals with obesity or who are overweight with at least one weight-related comorbidity. It also authorizes Medicare to cover intensive behavioral therapy for obesity provided by additional types of healthcare providers. The legislation affects Medicare beneficiaries and healthcare providers nationwide.

Timeline

Every recorded action, oldest first.

July 19, 2024 · House
Introduced
This bill allows for Medicare Part D coverage of anti-obesity drugs and expands intensive behavioral therapy for obesity to more healthcare providers. It was the most-viewed bill for the week of July 19, 2026.
Next: Referred to the House Committee on Energy and Commerce.
Source
July 22, 2024 · House
Reported from committee
Expands Medicare Part D coverage to include FDA-approved weight-loss medications. The bill was reported from the House Committee on Ways and Means.
Next: Awaits a floor vote in the House.
Source
July 26, 2024 · House
Introduced
The bill expands Medicare coverage to include chronic weight management drugs and broadens the range of healthcare providers authorized to provide intensive behavioral therapy for obesity.
Next: Referred to the House Committee on Energy and Commerce.
Source
July 26, 2025 · House
Introduced
Expands Medicare coverage to include intensive behavioral therapy for obesity and weight-loss drugs. This bill has consistently been the most-viewed piece of legislation.
Next: Referred to the House Committee on Energy and Commerce.
Source
July 19, 2026 · House
Introduced
The most viewed bill as of July 19, 2026, it aims to reduce obesity by allowing Medicare Part D to cover weight loss drugs and improving access to intensive behavioral therapy.
Next: Referred to the House Committee on Energy and Commerce.
Source
July 19, 2026 · House
Debated
A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of obesity drugs and expanded access to therapy.
Next: Pending further action in the House.
Source
July 19, 2026 · House
Reported from committee
The bill expands Medicare coverage for obesity-related medications and behavioral therapy. It was the most-viewed bill for the week of July 19, 2026.
Next: Awaits potential floor consideration in the House.
Source
July 26, 2026 · House
Introduced
This bill expands Medicare coverage to include medications and additional behavioral therapy for the treatment of obesity. It is currently the most viewed bill for the week of July 26, 2026.
Next: Referred to House committees for consideration.
Source
August 2, 2026 · House
Introduced
Expands Medicare coverage to include medications and additional behavioral therapy for chronic weight management. The bill was the most viewed piece of legislation on Congress.gov as of early August 2026.
Next: Referred to House committees for consideration.
Source
August 2, 2026 · House
Debated
The Treat and Reduce Obesity Act of 2023 expands Medicare coverage to include anti-obesity medications and behavioral therapy from a broader range of providers. It was the most-viewed bill for the week of August 2, 2026.
Next: Referred to the House Committee on Energy and Commerce.
Source
August 2, 2026 · House
Reported from committee
Expands Medicare coverage to include obesity medication and behavioral therapy; was the most-viewed bill for the week of August 2, 2026.
Next: Awaits scheduling for a House floor vote.
Source